Benoît Tessoulin

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun et al. · Blood Advances · 2020 · 387 citations · Full text

PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance

Benoît Tessoulin, Géraldine Descamps, Philippe Moreau et al. · Blood · 2014 · 163 citations · Full text

Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial

Steven Le Gouill, Franck Morschhauser, David Chiron et al. · Blood · 2020 · 127 citations · Full text

Description of neurotoxicity in a series of patients treated with CAR T-cell therapy

Cathérine Belin, Perrine Devic, Xavier Ayrignac et al. · Scientific Reports · 2020 · 116 citations · Full text

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Élie Azoulay, Pedro Castro, Adel Maamar et al. · The Lancet Haematology · 2021 · 91 citations

Clinical Immunology, Translational Medicine, Cell Therapy +8